TY - JOUR
T1 - Basic clinical and Laboratory features of filoviral hemorrhagic fever
AU - Kortepeter, Mark G.
AU - Bausch, Daniel G.
AU - Bray, Mike
PY - 2011/11/1
Y1 - 2011/11/1
N2 - The filoviruses Marburg and Ebola cause severe hemorrhagic fever (HF) in humans. Beginning with the 1967 Marburg outbreak, 30 epidemics, isolated cases, and accidental laboratory infections have been described in the medical literature. We reviewed those reports to determine the basic clinical and laboratory features of filoviral HF. The most detailed information was found in descriptions of patients treated in industrialized countries; except for the 2000 outbreak of Ebola Sudan HF in Uganda, reports of epidemics in central Africa provided little controlled or objective clinical data. Other than the case fatality rate, there were no clear differences in the features of the various filovirus infections. This compilation will be of value to medical workers responding to epidemics and to investigators attempting to develop animal models of filoviral HF. By identifying key unanswered questions and gaps in clinical data, it will help guide clinical research in future outbreaks.
AB - The filoviruses Marburg and Ebola cause severe hemorrhagic fever (HF) in humans. Beginning with the 1967 Marburg outbreak, 30 epidemics, isolated cases, and accidental laboratory infections have been described in the medical literature. We reviewed those reports to determine the basic clinical and laboratory features of filoviral HF. The most detailed information was found in descriptions of patients treated in industrialized countries; except for the 2000 outbreak of Ebola Sudan HF in Uganda, reports of epidemics in central Africa provided little controlled or objective clinical data. Other than the case fatality rate, there were no clear differences in the features of the various filovirus infections. This compilation will be of value to medical workers responding to epidemics and to investigators attempting to develop animal models of filoviral HF. By identifying key unanswered questions and gaps in clinical data, it will help guide clinical research in future outbreaks.
UR - http://www.scopus.com/inward/record.url?scp=80054741233&partnerID=8YFLogxK
U2 - 10.1093/infdis/jir299
DO - 10.1093/infdis/jir299
M3 - Article
C2 - 21987756
AN - SCOPUS:80054741233
SN - 0022-1899
VL - 204
SP - S810-S816
JO - Journal of Infectious Diseases
JF - Journal of Infectious Diseases
IS - SUPPL. 3
ER -